KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Assets Average: 2020-2025

Historic Assets Average for Royalty Pharma (RPRX) over the last 5 years, with Sep 2025 value amounting to $18.8 billion.

  • Royalty Pharma's Assets Average rose 5.52% to $18.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $18.8 billion, marking a year-over-year increase of 5.52%. This contributed to the annual value of $17.3 billion for FY2024, which is 4.25% up from last year.
  • Latest data reveals that Royalty Pharma reported Assets Average of $18.8 billion as of Q3 2025, which was up 4.84% from $18.0 billion recorded in Q2 2025.
  • In the past 5 years, Royalty Pharma's Assets Average registered a high of $18.8 billion during Q3 2025, and its lowest value of $16.0 billion during Q1 2021.
  • Over the past 3 years, Royalty Pharma's median Assets Average value was $17.1 billion (recorded in 2023), while the average stood at $17.3 billion.
  • Its Assets Average has fluctuated over the past 5 years, first dropped by 6.88% in 2023, then increased by 12.49% in 2024.
  • Over the past 5 years, Royalty Pharma's Assets Average (Quarterly) stood at $17.6 billion in 2021, then dropped by 2.16% to $17.2 billion in 2022, then fell by 6.52% to $16.1 billion in 2023, then rose by 12.49% to $18.1 billion in 2024, then rose by 5.52% to $18.8 billion in 2025.
  • Its last three reported values are $18.8 billion in Q3 2025, $18.0 billion for Q2 2025, and $17.9 billion during Q1 2025.